ישראל - עברית - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - טבליות בשחרור ממושך - melatonin 2 mg - melatonin - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

ישראל - עברית - Ministry of Health

neurim pharmaceuticals limited - melatonin 2 mg - tablets - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

ישראל - עברית - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - טבליות בשחרור ממושך - melatonin 2 mg - melatonin

ישראל - עברית - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - טבליות בשחרור ממושך - melatonin 1 mg - melatonin

ישראל - עברית - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - טבליות בשחרור ממושך - melatonin 5 mg - melatonin

ישראל - עברית - Ministry of Health

neuronix - צוות טכני - טיפול בחולי אלצהיימר בשלב קל עד בינוני

ישראל - עברית - Ministry of Health

neuronix - צוות טכני - טיפול בחולי אלצהיימר במצב קל עד בינוני

ישראל - עברית - Ministry of Health

talshir medical techn - טיפול בעין עצלה ושיפור ראיה לפי התוויות יצרן

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - תרחיף - aciclovir 200 mg / 5 ml - aciclovir - aciclovir - zovirax oral presentations are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes, for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients, for the prophylaxis of herpes simplex infections in immune-compromised patients and for the treatment of herpes zoster (shingles) infections. studies have shown that early treatment of shingles with zovirax has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster associated pain). zovirax oral presentations should be considered for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving sho

ישראל - עברית - Ministry of Health

בפקס בע"מ - מומחה - לשימוש בבתי חולים ואוניברסיטאות